Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Logo for

Science 328 (5979): 697-698

Copyright © 2010 by the American Association for the Advancement of Science


Tumor Immune Evasion

Carlene L. Zindl1, and David D. Chaplin2

Many types of human tumors can suppress the immune system to enhance their survival. Some tumor cells escape immune detection by decreasing the expression of certain antigen-presenting proteins at their surface, rendering them invisible to cytotoxic T lymphocytes (1). But more often, tumors secrete proteins that inhibit effector T cell responses and promote the production of regulatory T cells that suppress immune responses (2). On page 749 of this issue, Shields et al. (3) identify another mechanism by which tumors deceive the immune system. Certain melanomas can reorganize their stromal microenvironment (the supportive connective tissue) into structures similar to lymphoid tissue of the immune system. This ingenious reconstruction recruits and maintains immune regulatory cells that promote tolerance and tumor progression.

1 Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
2 Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

E-mail: dchaplin{at}

Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells.
L. Wang, J. Qian, Y. Lu, H. Li, H. Bao, D. He, Z. Liu, Y. Zheng, J. He, Y. Li, et al. (2013)
Haematologica 98, 1458-1466
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882